Yeah, that was not only painful, but outright disingenuous toward shareholders. I held through that and am happy to see it's mostly recovered now. They will indeed need to raise more funds, but they're about as close to turning the corner as they can be. And IMO the share price doesn't price in success in even one of their candidate drugs. RDHL is also one of my largest holdings today.
News 
Market Data 
Discover 
